Promino Nutritional Sciences Inc. MUSLF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 70.79% | 317.78% | 718.00% | 583.23% | 199.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.79% | 317.78% | 718.00% | 583.23% | 199.21% |
| Cost of Revenue | 41.26% | 128.86% | 182.83% | 55.32% | -39.78% |
| Gross Profit | 190.61% | 219.46% | 232.81% | 119.56% | 91.73% |
| SG&A Expenses | 68.18% | -16.97% | -46.44% | -93.63% | -79.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.36% | 4.75% | -27.49% | -81.45% | -71.36% |
| Operating Income | -44.79% | 31.06% | 56.26% | 94.87% | 80.17% |
| Income Before Tax | 23.66% | 38.28% | 58.92% | 90.53% | 67.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.66% | 38.28% | 58.92% | 90.53% | 67.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.66% | 38.28% | 58.92% | 90.53% | 67.21% |
| EBIT | -44.79% | 31.06% | 56.26% | 94.87% | 80.17% |
| EBITDA | -- | -- | -- | 110.89% | 94.56% |
| EPS Basic | 45.85% | 66.52% | 80.55% | 96.23% | 85.56% |
| Normalized Basic EPS | 13.79% | 55.43% | 76.13% | 95.13% | 87.87% |
| EPS Diluted | 40.55% | 63.44% | 78.70% | 96.26% | 84.72% |
| Normalized Diluted EPS | 13.79% | 55.43% | 76.13% | 95.13% | 87.87% |
| Average Basic Shares Outstanding | 34.46% | 44.01% | 58.59% | 94.78% | 70.91% |
| Average Diluted Shares Outstanding | 34.46% | 44.01% | 58.59% | 94.78% | 70.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |